Medicine. Old drug, new hope for Marfan syndrome.
Travis
John
J
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000818:Animals; D001014:Aortic Aneurysm / Q000209:etiology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D004646:Emphysema / Q000209:etiology / Q000517:prevention & control; D000071837:Fibrillins; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D008382:Marfan Syndrome / Q000150:complications* / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D051379:Mice; D008840:Microfilament Proteins / Q000235:genetics / Q000378:metabolism; D009154:Mutation; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors / Q000378:metabolism
D000319:Adrenergic beta-Antagonists; D047228:Angiotensin II Type 1 Receptor Blockers; D000071837:Fibrillins; D008840:Microfilament Proteins; D016212:Transforming Growth Factor beta; D019808:Losartan